Jeremy Goldhaber-Fiebert
Publication Details
-
The business case for quality improvement: oral anticoagulation for atrial fibrillation.
Circ Cardiovasc Qual Outcomes. 2011; (4): 416-24
The potential to save money within a short time frame provides a more compelling "business case" for quality improvement than merely demonstrating cost-effectiveness. Our objective was to demonstrate the potential for cost savings from improved control in patients anticoagulated for atrial fibrillation.
Help